|
CALU expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.62825350161711E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.30719995833562E-09 |
| Normal-vs-Stage2 |
3.402600E-03 |
| Normal-vs-Stage3 |
4.22980000025497E-07 |
| Normal-vs-Stage4 |
2.27829999976947E-07 |
| Stage1-vs-Stage2 |
6.055000E-01 |
| Stage1-vs-Stage3 |
1.619620E-01 |
| Stage1-vs-Stage4 |
1.372440E-02 |
| Stage2-vs-Stage3 |
7.448000E-01 |
| Stage2-vs-Stage4 |
2.171800E-01 |
| Stage3-vs-Stage4 |
2.126000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.52478071572204E-13 |
| Normal-vs-AfricanAmerican |
6.104000E-02 |
| Normal-vs-Asian |
5.856100E-02 |
| Caucasian-vs-AfricanAmerican |
5.49149999917731E-08 |
| Caucasian-vs-Asian |
7.335200E-01 |
| AfricanAmerican-vs-Asian |
1.273380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.24005275334594E-12 |
| Normal-vs-Female |
1.00099999955638E-07 |
| Male-vs-Female |
2.302100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.708060E-02 |
| Normal-vs-Age(41-60Yrs) |
7.1148997804471E-10 |
| Normal-vs-Age(61-80Yrs) |
1.83549953014506E-10 |
| Normal-vs-Age(81-100Yrs) |
1.091990E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.374000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.833000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.061200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.753000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.510400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.442000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.718600E-03 |
| Normal-vs-Grade 2 |
5.45389999828672E-09 |
| Normal-vs-Grade 3 |
1.76300000154228E-08 |
| Normal-vs-Grade 4 |
2.17400000002144E-07 |
| Grade 1-vs-Grade 2 |
8.087400E-01 |
| Grade 1-vs-Grade 3 |
7.094600E-01 |
| Grade 1-vs-Grade 4 |
2.019700E-02 |
| Grade 2-vs-Grade 3 |
5.298400E-01 |
| Grade 2-vs-Grade 4 |
4.738300E-03 |
| Grade 3-vs-Grade 4 |
1.324120E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.31590000299553E-08 |
| Normal-vs-ccB subtype |
2.56206167392747E-12 |
| ccA subtype-vs-ccB subtype |
2.32450000003936E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.48259959864561E-10 |
| Normal-vs-N1 |
7.344600E-03 |
| N0-vs-N1 |
9.952300E-02 |
|
|
